Literature DB >> 2689749

Dysmorphism of urinary red blood cells--value in diagnosis.

C Pollock1, P L Liu, A Z Györy, R Grigg, E D Gallery, R Caterson, L Ibels, J Mahony, D Waugh.   

Abstract

To aid investigation into the clinical problem of hematuria, assessment of abnormalities in the shape of red cells in the urine (dysmorphism) is gaining popularity in nephrology. However, there is uncertainty in the literature regarding both the number of red blood cells (RBC) in normal urine, as well as the quantification of dysmorphism. We have shown that in normal urine (N = 27) the number of RBC is less than 2,000/ml as assessed by scanning electron microscopy of filtered urine specimens from normal volunteers without known renal disease, which compared to less than 1,000/ml by centrifugation and phase contrast microscopy of the same specimen. To determine whether dysmorphism of urinary red blood cells was a significant predictor of glomerular disease we compared the number of dysmorphic cells in the urine of patients with biopsy proven glomerulonephritis (GN), before and immediately after renal biopsy. We also compared the number of dysmorphic cells in patients with glomerulonephritis to those with lower urinary tract bleeding. Renal biopsy caused significant dysmorphic hematuria, indicating that dysmorphism suggests renal rather than glomerular bleeding. Although patients with GN had significantly more dysmorphic urinary RBC when compared to those with lower tract urinary bleeding, the overlap was such that one could only be confident of renal hematuria if they accounted for greater than 75% of the total number of RBC. Non renal hematuria is present if number of dysmorphic cells is less than 17% of total RBC. Thus dysmorphism of urinary RBC is a useful diagnostic tool, but only if strict criteria established for each laboratory are adhered to.

Entities:  

Mesh:

Year:  1989        PMID: 2689749     DOI: 10.1038/ki.1989.299

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  8 in total

Review 1.  Recognition and management of IgA nephropathy.

Authors:  L S Ibels; A Z Gyory; R J Caterson; C A Pollock; J F Mahony; D A Waugh; S Coulshed
Journal:  Drugs       Date:  1998-01       Impact factor: 9.546

Review 2.  [Hematuria in cases of bladder cancer].

Authors:  F Wawroschek; S Roth
Journal:  Urologe A       Date:  2003-02-25       Impact factor: 0.639

3.  Validity of G1-cells in the differentiation between glomerular and non-glomerular haematuria in children.

Authors:  B Lettgen; A Wohlmuth
Journal:  Pediatr Nephrol       Date:  1995-08       Impact factor: 3.714

4.  Diagnostic impact of dysmorphic red blood cells on evaluating microscopic hematuria: the urologist's perspective.

Authors:  Kyo Chul Koo; Kwang Suk Lee; Ah Ran Choi; Koon Ho Rha; Sung Joon Hong; Byung Ha Chung
Journal:  Int Urol Nephrol       Date:  2016-03-28       Impact factor: 2.370

5.  The value of urinary red cell shape in the diagnosis of glomerular and post-glomerular haematuria. A meta-analysis.

Authors:  M Offringa; J Benbassat
Journal:  Postgrad Med J       Date:  1992-08       Impact factor: 2.401

6.  Enhancing the Detection of Dysmorphic Red Blood Cells and Renal Tubular Epithelial Cells with a Modified Urinalysis Protocol.

Authors:  Yu Chu-Su; Kenichi Shukuya; Takashi Yokoyama; Wei-Chou Lin; Chih-Kang Chiang; Chii-Wann Lin
Journal:  Sci Rep       Date:  2017-01-11       Impact factor: 4.379

7.  Posterior nutcracker syndrome associated with interrupted left inferior vena cava with azygos continuation and retroaortic right renal vein.

Authors:  Xiao-Li Luo; Gen-Nian Qian; Hui Xiao; Chun-Lei Zhao; Xiao-Dong Zhou
Journal:  Korean J Radiol       Date:  2012-04-17       Impact factor: 3.500

8.  Dysmorphic erythrocytes are superior to hematuria for indicating non-diabetic renal disease in type 2 diabetics.

Authors:  Zhe-yi Dong; Yuan-da Wang; Qiang Qiu; Kai Hou; Li Zhang; Jie Wu; Han-yu Zhu; Guang-yan Cai; Xue-feng Sun; Xue-guang Zhang; Mo-yan Liu; Jia Kou; Xiang-mei Chen
Journal:  J Diabetes Investig       Date:  2015-06-11       Impact factor: 4.232

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.